First-line combination chemotherapy with
First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer
β
P. Periti; G. Robustelli Delia Cuna; F. Pannuti; T. Mazzei; P. Preti; A. Martoni
π
Article
π
1985
π
Springer US
π
English
β 312 KB
In this study, 30 evaluable patients with advanced carcinoma of the breast were treated with cyclophosphamide 600 mg/m2 i.v. followed one day later with mitoxantrone (Novantrone; dihydroxyanthracenedione) 16 mg/m2 i.v. Drug treatment was repeated every 3-4 weeks, for a maximum of 12 cycles. The over